Evidence map›Paper›PMID 31744486›Full record

ArticleBMC complementary and alternative medicine2019

Weipiling ameliorates gastric precancerous lesions in Atp4a

Wei Liu, Zi-Ming Zhao, Yuan-Liang Liu, Hua-Feng Pan, Li-Zhu Lin

RetractedAbstract readRetracted Publication
In one paragraph

Article in BMC complementary and alternative medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Natural products targeting glycolysis in cancer.Frontiers in pharmacology · 2022
    Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Role and mechanism of Glut-1 and H+/K+-ATPase expression in pepsin-induced development of vocal cord leukoplakia.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2022
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Wei LiuGuangzhou University of Chinese Medicine, Guangzhou, 510405, Guangdong, China.
Zi-Ming ZhaoGuangdong Province Engineering Technology Research Institute of T.C.M, Guangzhou, 510095, China.
Yuan-Liang LiuGuangzhou University of Chinese Medicine, Guangzhou, 510405, Guangdong, China.
Hua-Feng PanGuangzhou University of Chinese Medicine, Guangzhou, 510405, Guangdong, China. gzphf@126.com.
Li-Zhu LinGuangzhou University of Chinese Medicine, Guangzhou, 510405, Guangdong, China. lizhulin26@yahoo.com.

Funding

National Natural Science Foundation of China 81673946Natural Science Foundation of Guangdong Province 2017A030313845
6 · The paper itself

Abstract

backgroundAltered cellular metabolism is considered to be one of the hallmarks of cancer (Coller, Am J Pathol 184:4-17, 2014; Kim and Bae, Curr Opin Hematol 25:52-59, 2018). However, few studies have investigated the role of metabolism in the development of gastric precancerous lesions (GPLs). Weipiling (WPL), a traditional Chinese medicine formula for treatment of GPLs. In this study, we evaluated the amelioration of GPLs by WPL and investigated the possible role of WPL in regulating glucose metabolism.

methodsFirstly, the major components of WPL are chemically characterized by HPLC analytical method. In this study, we chose the Atp4a

resultsIn this work, we evaluated the protective effect of WPL on gastric mucosa in mice with precancerous lesions. The aberrant apoptosis in gastric mucosa of gastric pre-cancerous lesions was controlled by WPL (P<0.05). Furthermore, WPL suppressed the expression of CDX2, MUC2, ki-67, PTEN and p53, as the levels of these proteins decreased significantly compared with the model group (P<0.05). In parallel, WPL significantly suppressed the expression of transporters, such as HK-II, PKM2, ENO1, MPC1 and LDHA (P<0.05). In addition, mTOR, HIF-1a, AMPK, Rheb, TSC1 and TSC2 protein levels in gastric mucosa of Atp4a

conclusionsConclusively, WPL could ameliorate GPLs in Atp4a

Indexed as

AnimalsDrugs, Chinese HerbalGastric MucosaH(+)-K(+)-Exchanging ATPaseHumansHypoxia-Inducible Factor 1, alpha SubunitMaleMiceMice, Inbred C57BLMice, KnockoutPrecancerous ConditionsTOR Serine-Threonine KinasesTuberous Sclerosis Complex 1 ProteinAtp4a protein, mouseDrugs, Chinese HerbalHif1a protein, mouseH(+)-K(+)-Exchanging ATPaseHypoxia-Inducible Factor 1, alpha SubunitmTOR protein, mouseTOR Serine-Threonine KinasesTsc1 protein, mouseTuberous Sclerosis Complex 1 ProteinAtp4a−/−miceGastric precancerous lesionsGlycolysismTOR/HIF-1α pathwaysTraditional Chinese medicineWeipiling

Identifiers

PMID31744486
PMCPMC6862855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.